BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35312883)

  • 1. B7 homolog 3 induces lung metastasis of breast cancer through Raf/MEK/ERK axis.
    Wang S; Zhang X; Ning H; Dong S; Wang G; Sun R
    Breast Cancer Res Treat; 2022 Jun; 193(2):405-416. PubMed ID: 35312883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
    Liu Z; Zhang W; Phillips JB; Arora R; McClellan S; Li J; Kim JH; Sobol RW; Tan M
    Oncogene; 2019 Jan; 38(1):88-102. PubMed ID: 30082909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
    Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
    J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H3-Induced Signaling in Lung Adenocarcinoma Cell Lines with Divergent Epidermal Growth Factor Receptor Mutation Patterns.
    Ding M; Liao H; Zhou N; Yang Y; Guan S; Chen L
    Biomed Res Int; 2020; 2020():8824805. PubMed ID: 33426073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.
    Wu GJ; Pen J; Huang Y; An S; Liu Y; Yang Y; Hao Q; Guo XX; Xu TR
    Mol Carcinog; 2018 Oct; 57(10):1396-1407. PubMed ID: 29917268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
    Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
    Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
    Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
    Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer.
    Ma Y; Zhan S; Lu H; Wang R; Xu Y; Zhang G; Cao L; Shi T; Zhang X; Chen W
    Cell Death Dis; 2020 Oct; 11(10):824. PubMed ID: 33011740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.
    Ning L; Kunnimalaiyaan M; Chen H
    Surgery; 2008 Dec; 144(6):920-4; discussion 924-5. PubMed ID: 19040998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
    Zhang X; Zhao Y; Yiminniyaze R; Zhu N; Zhang Y; Wumaier G; Xia J; Dong L; Zhou D; Wang J; Li C; Zhang Y; Li S
    Mol Carcinog; 2024 Jan; 63(1):61-74. PubMed ID: 37737453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PER3 plays anticancer roles in the oncogenesis and progression of breast cancer via regulating MEK/ERK signaling pathway.
    Liu Y; Wu Z; Li Y; Zhang J; Gao Y; Yuan G; Han M
    J Chin Med Assoc; 2022 Nov; 85(11):1051-1060. PubMed ID: 36278918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
    Cristea S; Sage J
    J Thorac Oncol; 2016 Aug; 11(8):1233-1241. PubMed ID: 27133774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
    Zhao Z; Zhang N; Li A; Zhou B; Chen Y; Chen S; Huang M; Wu F; Zhang L
    Cancer Lett; 2020 Aug; 485():14-26. PubMed ID: 32417396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.